title: Effects of MAPK inhibitors on CCR4-mediated chemotaxis against thymus and activation-regulated chemokine (TARC/CCL17).
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Moroi
authors.forename: Bin
authors.initials: B
authors.lastname: Yu
authors.forename: Kazunori
authors.initials: K
authors.lastname: Urabe
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Koga
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nakahara
authors.forename: Teruki
authors.initials: T
authors.lastname: Dainichi
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Uchi
authors.forename: Masutaka
authors.initials: M
authors.lastname: Furue
mesh_terms: D054414:Chemokine CCL17; D019742:Chemokines, CC / Q000502:physiology*; D002633:Chemotaxis / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D020935:MAP Kinase Signaling System / Q000187:drug effects*; D054398:Receptors, CCR4; D019707:Receptors, Chemokine / Q000502:physiology*
chemical_list: C106230:CCL17 protein, human; C515354:CCR4 protein, human; D054414:Chemokine CCL17; D019742:Chemokines, CC; D004791:Enzyme Inhibitors; D054398:Receptors, CCR4; D019707:Receptors, Chemokine